Important Safety Information On Actemra® (tocilizumab) - Risk Of Hepatotoxicity

ACTEMRA (tocilizumab) Safety Recall Summary ACTEMRA, a drug used to treat rheumatoid arthritis and other inflammatory conditions, is being recalled in Canada due to a risk of liver damage (hepatotoxicity). The recall affects all patients currently using this medication across Canada. The manufacturer has identified safety concerns related to how the drug affects liver function.

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2019-05-21

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/ecc8d093-8372-4053-8e58-7ed650bf807d